Literature DB >> 22160097

Prevalence of personality disorders using two diagnostic systems in psychiatric outpatients in Shanghai, China: a comparison of uni-axial and multi-axial formulation.

Tianhong Zhang1, Lanlan Wang, Mary-Jo D Good, Byron J Good, Annabelle Chow, Yunfei Dai, Junhan Yu, Haiyin Zhang, Zeping Xiao.   

Abstract

OBJECTIVE: To compare multi-axial (DSM-IV) with uni-axial diagnostic system (CCMD-3, Chinese Classification and Diagnostic Criteria of Mental Disorders) as diagnostic methods to determine the prevalence of personality disorders (PDs) in Chinese psychiatric outpatients.
METHOD: 3,075 outpatients were randomly sampled from clinical settings in China. CCMD-3 PDs were evaluated as per routine psychiatric practice. DSM-IV PDs were assessed using both self-reported questionnaire and structured clinical interview.
RESULTS: The prevalence estimate for any type of PD in the total sample is 31.93% as reflected in the DSM-IV. This figure is nearly 110 times as large as the prevalence estimate for the CCMD-3. Only 9 outpatients were diagnosed with PD based on the CCMD-3. Amongst the 10 forms of DSM-IV PDs, avoidant (8.1%), obsessive-compulsive (7.6%), paranoid (6.0%), and borderline (5.8%) PDs were the most prevalent subtypes. This study found that PDs are commonly associated with the following: (i) the younger aged; (ii) single marital status; (iii) those who were not raised by their parents; (iv) introverted personalities; (v) first-time seekers of psycho-counseling treatment; and (vi) patients with co-morbid mood or anxiety disorders.
CONCLUSIONS: PDs are easily overlooked when the diagnosis is made based on the CCMD-3 uni-axial diagnostic system. However, it was found that personality pathology is common in the Chinese psychiatric community when using the DSM-IV classification system. Existing evidence suggest, at least indirectly, that there are important benefits of moving towards a multi-axial diagnostic approach in psychiatric practice.

Entities:  

Mesh:

Year:  2011        PMID: 22160097      PMCID: PMC4144990          DOI: 10.1007/s00127-011-0445-x

Source DB:  PubMed          Journal:  Soc Psychiatry Psychiatr Epidemiol        ISSN: 0933-7954            Impact factor:   4.328


  35 in total

1.  Patterns of comorbidity among DSM-III-R personality disorders.

Authors:  M G Marinangeli; G Butti; A Scinto; L Di Cicco; C Petruzzi; E Daneluzzo; A Rossi
Journal:  Psychopathology       Date:  2000 Mar-Apr       Impact factor: 1.944

Review 2.  Personality disorders and mood disorders: perspectives on diagnosis and classification from studies of longitudinal course and familial associations.

Authors:  Andrew E Skodol; M Tracie Shea; Shirley Yen; Candace N White; John G Gunderson
Journal:  J Pers Disord       Date:  2010-02

3.  Twelve-month outcome in bipolar patients with and without personality disorders.

Authors:  E Dunayevich; K W Sax; P E Keck; S L McElroy; M T Sorter; B J McConville; S M Strakowski
Journal:  J Clin Psychiatry       Date:  2000-02       Impact factor: 4.384

4.  Factors predicting the clinical course of generalised anxiety disorder.

Authors:  K A Yonkers; I R Dyck; M Warshaw; M B Keller
Journal:  Br J Psychiatry       Date:  2000-06       Impact factor: 9.319

5.  Age-related differences in the frequency of personality disorders among inpatient veterans.

Authors:  M M Kenan; E M Kendjelic; V A Molinari; W Williams; M Norris; M E Kunik
Journal:  Int J Geriatr Psychiatry       Date:  2000-09       Impact factor: 3.485

6.  Personality disorders and traits in patients with body dysmorphic disorder.

Authors:  K A Phillips; S L McElroy
Journal:  Compr Psychiatry       Date:  2000 Jul-Aug       Impact factor: 3.735

7.  Shame, personality, and social anxiety symptoms in Chinese and American nonclinical samples: a cross-cultural study.

Authors:  Jie Zhong; Aimin Wang; Mingyi Qian; Lili Zhang; Jun Gao; Jianxiang Yang; Bo Li; Ping Chen
Journal:  Depress Anxiety       Date:  2008       Impact factor: 6.505

8.  Categorical and dimensional stability of comorbid personality disorder symptoms in DSM-IV major depressive disorder: a prospective study.

Authors:  Tarja K Melartin; Jari Haukka; Heikki J Rytsälä; Pekka J Jylhä; Erkki T Isometsä
Journal:  J Clin Psychiatry       Date:  2010-01-12       Impact factor: 4.384

9.  Screening of personality disorders among chinese college students by Personality Diagnostic Questionnaire-4+.

Authors:  Xiting Huang; Hui Ling; Bingjun Yang; Gang Dou
Journal:  J Pers Disord       Date:  2007-08

10.  The prevalence of personality disorder, its comorbidity with mental state disorders, and its clinical significance in community mental health teams.

Authors:  Giles Newton-Howes; Peter Tyrer; Katina Anagnostakis; Sylvia Cooper; Owen Bowden-Jones; Tim Weaver
Journal:  Soc Psychiatry Psychiatr Epidemiol       Date:  2009-06-20       Impact factor: 4.328

View more
  16 in total

1.  The Heart of the Meaning: Honoring the Work of Byron J. Good.

Authors:  Atwood D Gaines
Journal:  Cult Med Psychiatry       Date:  2018-12

2.  A compromise solution between overlapping and overlooking DSM personality disorders in Chinese psychiatric practice.

Authors:  SuoYu Zhu; TianHong Zhang; ChengQing Yang; YanYan Wei; LiHua Xu; JunJie Wang; Annabelle Chow; XiaoHua Liu; KaiDa Jiang; ZePing Xiao; Hui Zhou; JiJun Wang
Journal:  Soc Psychiatry Psychiatr Epidemiol       Date:  2017-09-27       Impact factor: 4.328

3.  Prodromal psychosis detection in a counseling center population in China: an epidemiological and clinical study.

Authors:  Tianhong Zhang; Huijun Li; Kristen A Woodberry; Larry J Seidman; Lina Zheng; Hui Li; Shanshan Zhao; Yingying Tang; Qian Guo; Xi Lu; Kaiming Zhuo; Zhenying Qian; Annabelle Chow; Chunbo Li; Kaida Jiang; Zeping Xiao; Jijun Wang
Journal:  Schizophr Res       Date:  2013-12-30       Impact factor: 4.939

4.  Age and remission of personality pathology in the psychotic disorders compared to mood and/or anxiety disorders.

Authors:  Tianhong Zhang; Mary-Jo D Good; Byron J Good; Annabelle Chow; Lanlan Wang; Yunfei Dai; Zeping Xiao
Journal:  Int J Psychiatry Med       Date:  2012       Impact factor: 1.210

5.  Childhood maltreatment profile in a clinical population in China: a further analysis with existing data of an epidemiologic survey.

Authors:  Tian Hong Zhang; Annabelle Chow; Lan Lan Wang; Jun Han Yu; Yun Fei Dai; Xi Lu; Mary-Jo D Good; Byron J Good; Ze Ping Xiao
Journal:  Compr Psychiatry       Date:  2013-04-15       Impact factor: 3.735

6.  Comorbid personality disorders among patients with depression.

Authors:  Nahathai Wongpakaran; Tinakon Wongpakaran; Vudhichai Boonyanaruthee; Manee Pinyopornpanish; Suthi Intaprasert
Journal:  Neuropsychiatr Dis Treat       Date:  2015-04-17       Impact factor: 2.570

7.  Co-morbidity of personality disorder in schizophrenia among psychiatric outpatients in China: data from epidemiologic survey in a clinical population.

Authors:  YanYan Wei; TianHong Zhang; Annabelle Chow; YingYing Tang; LiHua Xu; YunFei Dai; XiaoHua Liu; Tong Su; Xiao Pan; Yi Cui; ZiQiang Li; KaiDa Jiang; ZePing Xiao; YunXiang Tang; JiJun Wang
Journal:  BMC Psychiatry       Date:  2016-07-08       Impact factor: 3.630

8.  Factors Influencing Anxiety of Health Care Workers in the Radiology Department with High Exposure Risk to COVID-19.

Authors:  Lei Huang; Yun Wang; Juan Liu; Pengfei Ye; Xijian Chen; Huayan Xu; Haibo Qu; Gang Ning
Journal:  Med Sci Monit       Date:  2020-07-25

9.  Frequency of narcissistic personality disorder in a counseling center population in China.

Authors:  XueFeng Jiang; JunJie Wang; Wei Sun; LiHua Xu; XiaoChen Tang; HuiRu Cui; YanYan Wei; Li Hui; Yi Qiao; JiJun Wang; TianHong Zhang
Journal:  BMC Psychiatry       Date:  2019-07-05       Impact factor: 3.630

10.  Transdiagnostic Dimensions towards Personality Pathology and Childhood Traumatic Experience in a Clinical Sample: Subtype Classification by a Cross-sectional Analysis.

Authors:  JunJie Wang; Wei Sun; XiaoChen Tang; LiHua Xu; YanYan Wei; HuiRu Cui; YingYing Tang; Li Hui; QiuFang Jia; Hongliang Zhu; JiJun Wang; TianHong Zhang
Journal:  Sci Rep       Date:  2019-08-02       Impact factor: 4.379

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.